GEN Exclusives

More »

GEN News Highlights

Back to Item »

Promedior Raises $12M to Support Phase II Studies with Lead Antifibrotic Candidate

PRM-151 is designed to regulate monocyte-derived cells involved in fibrotic, inflammatory, and autoimmune diseases.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?